CCL1 and colorectal carcinoma: In conclusion, the present study revealed that TAMs at CRC primary and metastatic sites have different characteristics, suggesting that decreased CCL1 expression of TAMs at liver metastatic sites partly explains the unique slow tumour progression of CRC, providing for a grace period for radical resection of metastatic lesions.